Navigators Are Key in Encouraging Oral Therapy Adherence

December 2015 Vol 6, No 6
Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+; University Distinguished Service Professor of Breast Cancer, Administrative Director, The Johns Hopkins Breast Center; Director, John Hopkins Cancer Survivorship Programs; Professor of Surgery and Oncology, JHU School of Medicine; Co-Creator, Work Stride-Managing Cancer at Work
shockli@jhmi.edu

Welcome to our first newsletter in the Conquering the Multiple Myeloma Continuum series, which focuses on adherence to oral medications in patients with multiple myeloma (MM). In this first newsletter, you will learn about some of the major causes of nonadherence that patients and their providers face.

For those of you who know me, you know that I have several philosophies. One of them is that “You cannot manage what you do not measure.” Therefore, you will read about methods for assessing adherence, because, otherwise, you will not know how severe the problem is or the specific causes that prevent patients with MM from taking their medications as prescribed (see below). Barriers to adherence, interventional strategies for improving medication adherence, and adherence tools and resources are also discussed in detail. There is a great Health Belief Model that allows for better understanding of patients’ motivations, beliefs, and barriers so navigators can facilitate appropriate adherence interventions. This model consists of 5 concepts, including perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and cues to action.

You will also read information on how to incorporate compliance to oral therapy into the daily routine of patients with myeloma (see page 46). Cindy Chmielewski, a patient advocate and mentor, discusses challenges associated with oral oncolytics in patients with myeloma, how to overcome these barriers, and how to best support your patients.

In another commentary, we provide information and words of wisdom by Deborah Christensen, RN, BSN, HNB-BC, an oncology nurse navigator (see page 46). She explains how stressed patients are when they are dealing with a diagnosis like MM, which can result in the patient’s inability to listen and process information. Just because patients nod their heads up and down does not mean they retain anything. Oncology nurse navigators, however, have a proven track record of being some of the most trusted people in the eyes of their patients. Patients will confide in navigators the difficulties they are experiencing with taking their medications as prescribed. This, in turn, allows the opportunity for a successful intervention.

We know this type of information will enable you to better support your patients and treat them more effectively. We must make sure patients’ responsibilities to take their medications as prescribed can happen consistently, confidently, and easily.

Related Articles
The Value of Palliative Care Early in the Treatment Process
Lillie D. Shockney, RN, BS, MAS, ONN-CG
|
Best Practices in Breast Cancer – October 2018 Vol 9
Palliative care has a serious identity problem. Seventy percent of Americans describe themselves as “not at all knowledgeable” about palliative care, and most healthcare professionals believe it is synonymous with end-of-life care.1 This perception is not far from current medical practice, because specialty palliative care—administered by clinicians with expertise in palliative medicine—is predominantly offered through hospice care or inpatient consultation only after life-prolonging treatment has failed. This means that the majority of patients who could benefit from palliative care are not receiving it until they are very close to death. To ensure that patients with metastatic breast cancer receive the best cancer care throughout their disease trajectory, palliative care should be initiated alongside standard oncology care, and it should be implemented early.
Recognizing Progress and Encouraging Further Strides in Breast Cancer
Lillie D. Shockney, RN, BS, MAS, ONN-CG
|
Best Practices in Breast Cancer – October 2018 Vol 9
In addition to the obligatory orange and black decorations of October, it’s also the time of year to don your pink in honor of Breast Cancer Awareness Month! The progress we have made as a nation in elevating the importance of regular breast cancer screenings, funding research, and supporting breast cancer survivors has had a direct impact on our ability to increase and improve survivorship.
“Establishing a Successful Navigation Program”: A JONS Exclusive Series
Lillie D. Shockney, RN, BS, MAS, ONN-CG
|
October 2018 Vol 9, NO 10

How do you establish a successful navigation program? The answers are right here in this issue!

Last modified: June 11, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code